
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
At the beginning your call night, you receive a sign-out from the emergency department (ED) of a 19-month-old, full term, previously health boy with 5 days fever and neck swelling.






